Found 6 matching trials
Evaluation of Pharmacokinetics, Safety, And Tolerability Of Ertugliflozin (PF-04971729, MK-8835) In Japanese And Western Healthy Participants (MK-8835-041) PHASE1 This study is to characterize the pharmacokinetics, safety, tolerability, a...
Show More Location
Multiple Locations
Learn More & Join Trial
A Multiple Dose Study Of Ertugliflozin (PF-04971729, MK-8835) In Otherwise Healthy Overweight And Obese Volunteers (MK-8835-037) PHASE1 Ertugliflozin (PF-04971729, MK-8835) is under development for the treatment...
Show More Location
Multiple Locations
Learn More & Join Trial
Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016) PHASE2 MK-8835-016 (B1521006) is designed to evaluate the safety and efficacy of a...
Show More Location
Multiple Locations
Learn More & Join Trial
A Radiolabeled Mass Balance Study of [14C]-Ertugliflozin (PF04971729, MK-8835) In Healthy Male Participants (MK-8835-038) PHASE1 This is single dose study of radiolabeled \[14C\]-ertugliflozin (PF04971729...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042) PHASE2 MK-8835-042 (B1521004) is designed to assess the safety and efficacy of an ...
Show More Location
Multiple Locations
Learn More & Join Trial
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh PHASE4 The study titled "Efficacy and Safety of Omarigliptin, A Weekly Dipeptidyl ...
Show More Location
BIRDEM General Hospital
Learn More & Join Trial